Institutional shares held 79 Million
76K calls
85.8K puts
Total value of holdings $487M
$468K calls
$528K puts
Market Cap $412M
66,893,000 Shares Out.
Institutional ownership 118.08%
# of Institutions 189


Latest Institutional Activity in KURA

Top Purchases

Q2 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 56.9K ($351K)
Q2 2025
Harbor Capital Advisors, Inc. Shares Held: 47K ($290K)
Q2 2025
Pallas Capital Advisors LLC Shares Held: 13.3K ($82K)
Q2 2025
Parallel Advisors, LLC Shares Held: 641 ($3.95K)
Q2 2025
Versant Capital Management, Inc Shares Held: 1.24K ($7.61K)

Top Sells

Q2 2025
Aaron Wealth Advisors LLC Shares Held: 63.8K ($393K)
Q2 2025
Massmutual Trust CO Fsb Shares Held: 62 ($382)
Q2 2025
Farther Finance Advisors, LLC Shares Held: 33 ($203)
Q1 2025
Morgan Stanley Shares Held: 1.92M ($11.8M)
Q1 2025
Eco R1 Capital, LLC Shares Held: 2.64M ($16.3M)

About KURA

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.


Insider Transactions at KURA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
204K Shares
From 5 Insiders
Exercise of conversion of derivative security 22.7K shares
Grant, award, or other acquisition 181K shares
Sell / Disposition
49.1K Shares
From 7 Insiders
Open market or private sale 49.1K shares

Track Institutional and Insider Activities on KURA

Follow Kura Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KURA shares.

Notify only if

Insider Trading

Get notified when an Kura Oncology, Inc. insider buys or sells KURA shares.

Notify only if

News

Receive news related to Kura Oncology, Inc.

Track Activities on KURA